Cumberland Pharmaceuticals Files 2025 Proxy Statement
Ticker: CPIX · Form: DEF 14A · Filed: Mar 10, 2025 · CIK: 1087294
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: CPIX
TL;DR
CPix proxy statement out for 2024 fiscal year - shareholders vote soon.
AI Summary
Cumberland Pharmaceuticals Inc. filed its definitive proxy statement (DEF 14A) on March 10, 2025, for the fiscal year ending December 31, 2024. The filing provides details regarding the company's annual meeting and matters to be voted on by shareholders. The company is based in Nashville, TN, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the annual meeting, including any proposals, director elections, and executive compensation details, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is standard for public companies and does not inherently indicate new risks.
Key Numbers
- 2024 — Fiscal Year End (The proxy statement covers the company's performance and governance for this year.)
- 20250310 — Filing Date (This is the date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Registrant
- 20250310 (date) — Filing Date
- 20241231 (date) — Fiscal Year End
- 2834 (industry_code) — Standard Industrial Classification
- 615-255-0068 (phone_number) — Business Phone
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting, including details on voting matters, director nominations, and executive compensation.
When is the fiscal year end that this proxy statement pertains to?
The proxy statement pertains to the fiscal year ending December 31, 2024.
What is Cumberland Pharmaceuticals Inc.'s Standard Industrial Classification code?
Cumberland Pharmaceuticals Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Cumberland Pharmaceuticals Inc. headquartered?
Cumberland Pharmaceuticals Inc. is headquartered in Nashville, TN.
On what date was this definitive proxy statement filed?
This definitive proxy statement was filed on March 10, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 10, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).